Smith & Nephew plc (NYSE:SNN) Shares Sold by BKM Wealth Management LLC

BKM Wealth Management LLC trimmed its holdings in shares of Smith & Nephew plc (NYSE:SNN) by 5.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,055 shares of the medical equipment provider’s stock after selling 1,002 shares during the period. BKM Wealth Management LLC’s holdings in Smith & Nephew were worth $468,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Principal Securities Inc. boosted its holdings in Smith & Nephew by 87.6% in the 4th quarter. Principal Securities Inc. now owns 1,480 shares of the medical equipment provider’s stock worth $36,000 after acquiring an additional 691 shares during the period. R Squared Ltd acquired a new stake in Smith & Nephew during the 4th quarter valued at $41,000. GAMMA Investing LLC increased its stake in Smith & Nephew by 31.8% during the 4th quarter. GAMMA Investing LLC now owns 2,975 shares of the medical equipment provider’s stock worth $73,000 after buying an additional 718 shares during the period. Allspring Global Investments Holdings LLC lifted its holdings in Smith & Nephew by 74.4% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,025 shares of the medical equipment provider’s stock worth $94,000 after buying an additional 1,290 shares in the last quarter. Finally, Blue Trust Inc. boosted its position in Smith & Nephew by 460.5% in the 3rd quarter. Blue Trust Inc. now owns 4,658 shares of the medical equipment provider’s stock valued at $145,000 after buying an additional 3,827 shares during the last quarter. 25.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

SNN has been the subject of several research analyst reports. Berenberg Bank cut Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Wednesday, November 6th. Deutsche Bank Aktiengesellschaft downgraded shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Friday, November 1st. Finally, StockNews.com downgraded shares of Smith & Nephew from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, November 12th.

Smith & Nephew Trading Up 0.0 %

Shares of NYSE:SNN opened at $25.72 on Tuesday. Smith & Nephew plc has a fifty-two week low of $23.65 and a fifty-two week high of $31.72. The firm has a 50-day simple moving average of $25.02 and a 200 day simple moving average of $27.41. The company has a quick ratio of 1.11, a current ratio of 2.51 and a debt-to-equity ratio of 0.63.

About Smith & Nephew

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.